Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease.
10.7499/j.issn.1008-8830.2112094
- Author:
Hui-Min HU
1
;
Xiao-Zheng CHEN
;
Yong-Lan ZHANG
1
;
Zhong-Dong DU
1
Author Information
1. Department of Cardiology, Beijing Children's Hospital, Capital Medical University/National Center for Children's Health, Beijing 100045, China.
- Publication Type:Journal Article
- Keywords:
Child;
Coronary artery lesion;
Immunoglobulin;
Kawasaki disease;
Liver damage
- MeSH:
C-Reactive Protein/analysis*;
Child;
Coronary Vessels/pathology*;
Hemoglobins/analysis*;
Humans;
Immunoglobulins, Intravenous/therapeutic use*;
Liver Diseases;
Mucocutaneous Lymph Node Syndrome/drug therapy*;
Retrospective Studies
- From:
Chinese Journal of Contemporary Pediatrics
2022;24(6):681-686
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To summarize the clinical features of liver damage in children in the acute stage of Kawasaki disease (KD), and to investigate the clinical value of liver damage in predicting coronary artery lesion and no response to intravenous immunoglobulin (IVIG) in children with KD.
METHODS:The medical data were collected from 925 children who were diagnosed with KD for the first time in Beijing Children's Hospital from January 1, 2016 to December 31, 2017. According to the presence or absence of abnormal alanine aminotransferase (ALT) level on admission, the children were divided into a liver damage group (n=284) and a non-liver damage group (n=641). A logistic regression analysis was used to investigate the clinical value of the indicators including liver damage in predicting coronary artery lesion and no response to IVIG in children with KD.
RESULTS:Compared with the non-liver damage group, the liver damage group had a significantly earlier admission time and significantly higher serum levels of inflammatory indicators (P<0.05). The liver damage group had a significantly higher incidence rate of coronary artery lesion on admission than the non-liver damage group (P=0.034). After initial IVIG therapy, the liver damage group had a significantly higher proportion of children with no response to IVIG than the non-liver damage group (P<0.001). In children with KD, coronary artery lesion was associated with the reduction in the hemoglobin level and the increases in platelet count, C-reactive protein, and ALT (P<0.05), and no response to IVIG was associated with limb changes, the reduction in the hemoglobin level, the increases in platelet count, C-reactive protein, and ALT, and coronary artery lesion (P<0.05).
CONCLUSIONS:Compared with those without liver damage, the children in the early stage of KD with liver damage tend to develop clinical symptoms early and have higher levels of inflammatory indicators, and they are more likely to have coronary artery lesion and show no response to IVIG treatment.
